Yorita N, Yuge R, Takigawa H, Atsushi O, et al. Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy
attenuates excluded-type colorectal cancer in a mouse model. Cancer Lett 2020 Oct 28. pii: S0304-3835(20)30575.
PMID: 33129954